SPC501
Erdafitinib eða lyfjafræðilega viðunandi salt þar af eða lausnarsamband þar af / Erdafitinib or a pharmaceutically acceptable salt thereof or a solvate thereof
:
Umsókn:
14.2.2025:
15.3.2025
:
Balversa
14.2.2025
15.3.2025
:
EU/1/24/1841:
12.9.2024
:
EU/1/24/1841:
22.8.2024
:
Astex Therapeutics Limited:
436 Cambridge Science Park Milton Road, Cambridge Cambridgeshire CB4 0QA GB
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113 Reykjavík